Table 2 Antimicrobial resistance profile of bacteria isolated from blood samples, shown by proportion (percent)
GNB, n | MDR | AMP | AMK | GEN | CTX | CHL | CIP | OFX | TS | MEM | SAM | PTZ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Klebsiella spp., 16 | 12/16 (75) | 16/16 (100) | 8/16 (50) | 8/16 (50) | 13/16 (81) | 3/16 (19) | 8/16 (50) | 5/16 (31) | 8/16 (50) | 4/16 (25) | 10/16 (63) | 5/16 (31) |
Enterobacter spp., 11 | 9/11 (82) | 11/11 (100) | 1/11 (9) | 3/11 (27) | 8/11 (73) | 8/11 (73) | 2/11 (18) | 1/11 (9) | 2/11 (18) | 6/11 (55) | 5/11 (45) | 4/11 (36) |
Acinetobacter spp., 8 | 5/7 (71) | 7/7 (100) | 3/7 (43) | 3/7 (43) | 6/7 (86) | 6/7 (86) | 3/7 (43) | 2/7 (29) | 4/7 (57) | 3/7 (43) | 4/7 (57) | 2/7 (29) |
E coli, 3 | 0/3 (0) | 3/3 (100) | 0/3 (0) | 0/3 (0) | 0/3 (0) | 0/3 (0) | 0/3 (0) | 0/3 (0) | 0/3 (0) | 0/3 (0) | 1/3 (33) | 0/3 (0) |
Pseudomonas aeruginosa, 1 | 1/1 (100) | 1/1 (100) | 1/1 (100) | 1/1 (100) | 1/1 (100) | 1/1 (100) | 1/1 (100) | 1/1 (100) | 1/1 (100) | 0/1 (0) | 1/1 (100) | 0/1 (0) |
Total for GNB | 27/38 (71) | 38/38 (100) | 13/38 (34) | 15/38 (39) | 28/38 (74) | 18/38 (47) | 14/38 (37) | 9/38 (24) | 15/38 (39) | 13/38 (34) | 21/38 (55) | 11/38 (29) |
GPC | MDR | AMP | AMK | GEN | CTX | CHL | CIP | OFX | TS | ERY | CLI | OXA |
Staphylococcus aureus, 1 | 1/1 (100) | 1/1 (100) | 1/1 (100) | 1/1 (100) | 1/1 (100) | 0/1 (0) | 1/1 (100) | 1/1 (100) | 0/1 (0) | 1/1 (100) | 1/1 (100) | 1/1 (100) |
CoNS, 4 | 3/4 (75) | 4/4 (100) | 2/4 (50) | 3/4 (75) | 2/3 (67) | 1/4 (25) | 3/4 (75) | 2/3 (67) | 1/1 (100) | 3/3 (100) | 0/3 (0) | 2/3 (67) |
Total for GPC | 4/5 (80) | 5/5 (100) | 3/5 (60) | 4/5 (80) | 3/4 (75) | 1/5 (20) | 4/5 (80) | 3/4 (75) | 1/2 (50) | 4/4 (100) | 1/4 (25) | 3/4 (75) |
Total for GNB and GPC | 31/43 (72) | 43/43 (100) | 16/43 (37) | 19/43 (44) | 31/42 (74) | 19/43 (44) | 18/43 (42) | 12/42 (29) | 16/40 (40) | Â | Â | Â |